This is a summary of the original report published by Best Practices, LLC on New Pharmaceutical Drug Launch Spend and What it takes to Win in the U.S. Market.
The summary includes table of content and an overview of key insights and metrics discussed in the full report.
Pharmaceutical new product launches require many different activities and levels of investment. It is critical for launch teams to understand the right level of resources required for the key activities that give a new product its best chance for gaining a market foothold.
This study provides the current data on the funding levels of the key activities necessary to bring a new product into the U.S. market. Data are presented not only for launch year but also for each of the three years preceding product introduction. Brand and marketing leaders can use the results of this study to identify shifts in launch activity spending priorities across the industry and to compare spending levels for their own launch preparation programs against industry averages.